XML 79 R71.htm IDEA: XBRL DOCUMENT v3.22.2
Schedule of Restricted Stock Units (Details)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of Shares Outstanding, Awarded 343,512
Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares outstanding, beginning balance 170,068
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares $ 4.77
Number of Shares Outstanding, Awarded 343,512,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 2.61
Number of Shares Outstanding, Vested (170,068,000)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares $ 4.77
Number of Shares Outstanding, Canceled or expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | $ / shares
Share based compensation arrangement by share based payment award options vested and expected to vest outstanding number, ending balance 343,512,000
Weighted Average Remaining Contractual Life (in Years), Ending Balance 1 year 4 months 17 days
Total Intrinsic Value, Ending Balance | $ $ 639
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 2.61
Share based compensation arrangement by share based payment award options vested and expected to vest outstanding number, ending balance 343,512,000
Weighted Average Remaining Contractual Term, Ending Balance 1 year 4 months 17 days
Total Intrinsic Value Exercisable, Ending Balance | $ $ 639
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $ / shares $ 2.61